Recall: D-0120-2025

Class II - Potentially Harmful

Class IIClassification

2024-11-18Initiated

OngoingStatus

Viatris IncFirm

Product

Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC 0378-1815-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Reason

Superpotent Drug and Subpotent Drug: potency failures obtained

Distribution

Nationwide within the United States and Puerto Rico

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.